Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis.

Britney Barrera,Haley Simpson,Eric Engebretson,Stefan Sillau,Brooke Valdez,José Parra-González,Ryan C Winger, Lou Anne Epperson,Ashley Banks, Kathryn Pierce,Melanie Spotts, Katie O'Gean,Enrique Alvarez,Robert Gross,Amanda L Piquet,Teri Schreiner,John R Corboy,Jinglan Pei,Timothy L Vollmer,Kavita V Nair

Annals of clinical and translational neurology（2023）

Cited 1|Views20

No score

Abstract

IRRs and AEs occurred at acceptable rates during in-home infusions of ocrelizumab over a shorter infusion time. Patients reported increased confidence and comfort with the home infusion process. Findings from this study provide evidence of the safety and feasibility of home-based ocrelizumab infusion over a shorter infusion period.

Translated text

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined